Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Omega Healthcare Investors Inc. Common Stock (OHI) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance

Omega Healthcare Investors Inc. Common StockTrade
Dr. Reddy's Laboratories Ltd Common StockTrade

Price performance (Past 24H)

Key statistics

Omega Healthcare Investors Inc. Common Stock vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Omega Healthcare Investors Inc. Common Stock trades at $45 (market cap $13.70B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Omega Healthcare Investors Inc. Common Stock is the larger of the two by market cap, and Omega Healthcare Investors Inc. Common Stock pays the higher dividend (6.02%). Which is the better fit depends on your goals — on Pluang, investors hold Omega Healthcare Investors Inc. Common Stock for 0 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.

OHIRDY
Market Cap
$13.70B$10.78B
Volume
1,169,9532,724,343
Sector
Real EstateHealth
52-Week High
$51.72$15.38
52-Week Low
$39.53$11.38
Typical Hold Time
0 Days0 Days
Enterprise Value
$17.69B$10.68B
Dividend Yield
6.02%0.65%

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

OHI
100% Buy0% Sell
Avg holding period · 0 Days
RDY
100% Buy0% Sell
Avg holding period · 0 Days

About Omega Healthcare Investors Inc. Common Stock

Omega Healthcare Investors Inc. is a real estate investment trust that owns skilled nursing and assisted living facilities, which it leases to healthcare operators under long-term, primarily triple-net lease structures. It partners with healthcare providers across US and UK markets.

Read more on OHI →

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →